Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
2
×
fda
2
×
life sciences
national blog main
national top stories
new york blog main
san francisco blog main
age related macular degeneration
agios pharmaceuticals
american society of hematology
beta-thalassemia
biotech
blood diseases
bluebird bio
bortezomib
boston
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cemiplimab
center for medicare and medicaid services
clinical trials
companion diagnostic
cooley's anemia foundation
craig butler
daniel o'day
deals
detroit blog main
detroit top stories
diffuse large b-cell lymphoma
drugs
follicular lymphoma
foundation medicine
foundationone cdx
foundationone heme
gene therapy
genentech
geoffrey porges
What
big
2
×
acquire
agreed
american
ash
billion
blood
broad
confidence
country
didn’t
diego
disease
foundation
gain
gathering
genentech
hematology’s
largest
medical
medicine
meeting
momentum
morning
panels
pay
pays
picked
previewed
profiling
recently
redux
remaining
rest
roche
rolls
san
share
society
stock
Language
Current search:
big
×
fda
×
cancer
×
@xconomy.com
5 years ago
ASH 2018: Three Up, Two Down As The Big Blood Disease Meeting Rolls On
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine
